𝔖 Bobbio Scriptorium
✦   LIBER   ✦

mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene-expression levels

✍ Scribed by Sandra E. Ghayad; Ivan Bieche; Julie A. Vendrell; Celine Keime; Rosette Lidereau; Charles Dumontet; Pascale A. Cohen


Book ID
108584334
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
621 KB
Volume
99
Category
Article
ISSN
1347-9032

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Inhibition of proliferation and inductio
✍ Manuela Campiglio; Alberta Locatelli; Clelia Olgiati; Nicola Normanno; Giulia So πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 297 KB πŸ‘ 2 views

High expression of the epidermal growth factor receptor (EGFR) in breast carcinoma confers a growth advantage to the tumor cells. The EGFR tyrosine kinase inhibitor (EGFR-TKI) ZD1839 ('Iressa') has clinical activity in a wide range of tumor types, although the mechanism(s) by which it exerts its ant